貫葉連翹 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "貫葉連翹" in Chinese language version.

refsWebsite

Global rank Chinese rank

10nih.gov

4^th place

5^th place

9doi.org

2^nd place

23^rd place

2worldcat.org

5^th place

12^th place

1cancer.gov

1,684^th place

696^th place

1web.archive.org

1^st place

1semanticscholar.org

11^th place

332^nd place

139.net

low place

6,192^nd place

1dayi.org.cn

low place

39.net

ypk.39.net

舒肝解郁胶囊详细说明书-注意事项-不良反应-用法用量-39药品通. ypk.39.net.

cancer.gov

Questions and Answers About St. John's Wort. National Cancer Institute. 2024. （原始内容存档于October 2, 2024）（英国英语）.

dayi.org.cn

圣·约翰草提取物片_圣·约翰草提取物片的作用_圣·约翰草提取物片的用法用量_圣·约翰草提取物片的不良反应| 中国医药信息查询平台. www.dayi.org.cn.

doi.org

Fegert JM, Kölch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol. 2006, 16 (1–2): 197–206. PMID 16553540. doi:10.1089/cap.2006.16.197.
Nicolussi, Simon; Drewe, Jürgen; Butterweck, Veronika; Meyer, Henriette. Clinical relevance of St. John's wort drug interactions revisited. British Journal of Pharmacology. 19 November 2019, 177 (6): 1212–1226. PMC 7056460 . PMID 31742659. doi:10.1111/bph.14936.
Canning, S; Waterman, M; Orsi, N; Ayres, J; Simpson, N; Dye, L. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.. CNS drugs. 2010-03, 24 (3): 207–25. PMID 20155996. doi:10.2165/11530120-000000000-00000.
Demirci, B; Kahyaoğlu, F; Atakul, T; Yılmaz, M; Özoran, Y. Detrimental effect of Hypericum perforatum on ovarian functions.. Journal of the Turkish German Gynecological Association. 2019-05-28, 20 (2): 65–69. PMID 29755030. doi:10.4274/jtgga.galenos.2018.2018.0041.
Li, Y; Zhu, X; Bensussan, A; Li, P; Moylan, E; Delaney, G; McPherson, L. Herbal Medicine for Hot Flushes Induced by Endocrine Therapy in Women with Breast Cancer: A Systematic Review and Meta-Analysis.. Evidence-based complementary and alternative medicine : eCAM. 2016, 2016: 1327251. PMID 27418936. doi:10.1155/2016/1327251.
Liu, YR; Jiang, YL; Huang, RQ; Yang, JY; Xiao, BK; Dong, JX. Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety.. Climacteric : the journal of the International Menopause Society. 2014-08, 17 (4): 325–35. PMID 24188229. doi:10.3109/13697137.2013.861814.
Komoroski, Bernard J.; Zhang, Shimin; Cai, Hongbo; Hutzler, J. Matthew; et al. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 2004, 32 (5): 512–518. ISSN 0090-9556. PMID 15100173. doi:10.1124/dmd.32.5.512.
Chrubasik-Hausmann, Sigrun; Vlachojannis, Julia; McLachlan, Andrew J. Understanding drug interactions with St John's wort ( Hypericum perforatum L.): impact of hyperforin content. Journal of Pharmacy and Pharmacology. 2018-12-09, 71 (1): 129–138. ISSN 2042-7158. PMID 29411879. S2CID 46807341. doi:10.1111/jphp.12858  （英语）.
Cui, YH; Zheng, Y. A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults.. Neuropsychiatric disease and treatment. 2016, 12: 1715–23. PMC 4946846 . PMID 27468236. doi:10.2147/NDT.S106752.

nih.gov

ncbi.nlm.nih.gov

Fegert JM, Kölch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol. 2006, 16 (1–2): 197–206. PMID 16553540. doi:10.1089/cap.2006.16.197.
Nicolussi, Simon; Drewe, Jürgen; Butterweck, Veronika; Meyer, Henriette. Clinical relevance of St. John's wort drug interactions revisited. British Journal of Pharmacology. 19 November 2019, 177 (6): 1212–1226. PMC 7056460 . PMID 31742659. doi:10.1111/bph.14936.
Canning, S; Waterman, M; Orsi, N; Ayres, J; Simpson, N; Dye, L. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.. CNS drugs. 2010-03, 24 (3): 207–25. PMID 20155996. doi:10.2165/11530120-000000000-00000.
Demirci, B; Kahyaoğlu, F; Atakul, T; Yılmaz, M; Özoran, Y. Detrimental effect of Hypericum perforatum on ovarian functions.. Journal of the Turkish German Gynecological Association. 2019-05-28, 20 (2): 65–69. PMID 29755030. doi:10.4274/jtgga.galenos.2018.2018.0041.
Li, Y; Zhu, X; Bensussan, A; Li, P; Moylan, E; Delaney, G; McPherson, L. Herbal Medicine for Hot Flushes Induced by Endocrine Therapy in Women with Breast Cancer: A Systematic Review and Meta-Analysis.. Evidence-based complementary and alternative medicine : eCAM. 2016, 2016: 1327251. PMID 27418936. doi:10.1155/2016/1327251.
Liu, YR; Jiang, YL; Huang, RQ; Yang, JY; Xiao, BK; Dong, JX. Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety.. Climacteric : the journal of the International Menopause Society. 2014-08, 17 (4): 325–35. PMID 24188229. doi:10.3109/13697137.2013.861814.
Komoroski, Bernard J.; Zhang, Shimin; Cai, Hongbo; Hutzler, J. Matthew; et al. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 2004, 32 (5): 512–518. ISSN 0090-9556. PMID 15100173. doi:10.1124/dmd.32.5.512.
Chrubasik-Hausmann, Sigrun; Vlachojannis, Julia; McLachlan, Andrew J. Understanding drug interactions with St John's wort ( Hypericum perforatum L.): impact of hyperforin content. Journal of Pharmacy and Pharmacology. 2018-12-09, 71 (1): 129–138. ISSN 2042-7158. PMID 29411879. S2CID 46807341. doi:10.1111/jphp.12858  （英语）.
Cui, YH; Zheng, Y. A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults.. Neuropsychiatric disease and treatment. 2016, 12: 1715–23. PMC 4946846 . PMID 27468236. doi:10.2147/NDT.S106752.

pubmed.ncbi.nlm.nih.gov

Komoroski, Bernard J.; Zhang, Shimin; Cai, Hongbo; Hutzler, J. Matthew; et al. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 2004, 32 (5): 512–518. ISSN 0090-9556. PMID 15100173. doi:10.1124/dmd.32.5.512.

semanticscholar.org

api.semanticscholar.org

Chrubasik-Hausmann, Sigrun; Vlachojannis, Julia; McLachlan, Andrew J. Understanding drug interactions with St John's wort ( Hypericum perforatum L.): impact of hyperforin content. Journal of Pharmacy and Pharmacology. 2018-12-09, 71 (1): 129–138. ISSN 2042-7158. PMID 29411879. S2CID 46807341. doi:10.1111/jphp.12858  （英语）.

web.archive.org

Questions and Answers About St. John's Wort. National Cancer Institute. 2024. （原始内容存档于October 2, 2024）（英国英语）.

worldcat.org

Komoroski, Bernard J.; Zhang, Shimin; Cai, Hongbo; Hutzler, J. Matthew; et al. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 2004, 32 (5): 512–518. ISSN 0090-9556. PMID 15100173. doi:10.1124/dmd.32.5.512.
Chrubasik-Hausmann, Sigrun; Vlachojannis, Julia; McLachlan, Andrew J. Understanding drug interactions with St John's wort ( Hypericum perforatum L.): impact of hyperforin content. Journal of Pharmacy and Pharmacology. 2018-12-09, 71 (1): 129–138. ISSN 2042-7158. PMID 29411879. S2CID 46807341. doi:10.1111/jphp.12858  （英语）.